Integra LifeSciences IART Rest of World — Total Revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's rest of world — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's rest of world — total revenues?
- Integra LifeSciences (IART) reported rest of world — total revenues of $17.36M in Q1 2026.
- How has Integra LifeSciences's rest of world — total revenues changed year-over-year?
- Integra LifeSciences's rest of world — total revenues decreased by 13.2% year-over-year, from $20.01M to $17.36M.
- What is the long-term trend for Integra LifeSciences's rest of world — total revenues?
- Over 3 years (2022 to 2025), Integra LifeSciences's rest of world — total revenues has grown at a -2.0% compound annual growth rate (CAGR), from $83.48M to $78.58M.
- What does rest of world — total revenues mean?
- This metric represents the total net sales generated from geographic regions outside of the company's primary domestic and major international markets. It captures the revenue contribution from emerging or secondary global territories, reflecting the company's geographic diversification and international market penetration strategy. Tracking this figure helps investors assess the scale of global operations and the success of expansion efforts in non-core geographic segments.